Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 5.58% |
| Q3 2025 | -201.16% |
| Q2 2025 | 83.69% |
| Q1 2025 | -12320.77% |
| Q4 2024 | 98.81% |
| Q3 2024 | 21.75% |
| Q2 2024 | -425.62% |
| Q1 2024 | -285.44% |
| Q4 2023 | 95.50% |
| Q3 2023 | -166.17% |
| Q2 2023 | 237.99% |
| Q1 2023 | -123.37% |
| Q4 2022 | 450.85% |
| Q3 2022 | -22.36% |
| Q2 2022 | 28.75% |
| Q1 2022 | -17.28% |
| Q4 2021 | -136.79% |
| Q3 2021 | 44.77% |
| Q2 2021 | 22.57% |
| Q1 2021 | -487.64% |
| Q4 2020 | 55.07% |
| Q3 2020 | -81.98% |
| Q2 2020 | 25.31% |
| Q1 2020 | -52.81% |
| Q4 2019 | -162.20% |
| Q3 2019 | -133.01% |
| Q2 2019 | 265.31% |
| Q1 2019 | 8.33% |
| Q4 2018 | 15.04% |
| Q3 2018 | 16.88% |
| Q2 2018 | -1072.75% |
| Q1 2018 | -107.51% |
| Q4 2017 | 778.98% |
| Q3 2017 | 64.92% |
| Q2 2017 | 18.59% |
| Q1 2017 | -22.14% |
| Q4 2016 | 39.16% |
| Q3 2016 | -62.66% |
| Q2 2016 | 7.89% |
| Q1 2016 | -2.11% |